Determination of 44 major components and chemical profiling of saccharide in Chinese medicinal formula Lanqin Oral Liquid
Phytochemical Analysis · 2023
DOI: 10.1002/pca.3236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytochemical Analysis, 2023. Verfasst von Heng-Li Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development project of Shandong Province, State Key Laboratory of Natural Medicines, China Pharmaceutical University.
Abstract (Originalsprache)
Introduction
Lanqin Oral Liquid (LQL) is a traditional Chinese medicine preparation (TCMP) containing five herbal medicines and has been commonly used for the treatment of pharyngitis and hand‐foot‐and‐mouth disease in clinic. The material basis of LQL has been reported in our previous study, but the contents of the major components and the features of saccharide in LQL are still unclear.
Objectives
This study aimed to establish accurate and rapid methods for the quantification of the major components and profiling of saccharide in LQL. The quantitative results combined with similarity evaluation were applied to improve the quality control of LQL. Methodology An ultra‐high performance liquid chromatography coupled with triple‐quadrupole tandem mass spectrometry (UPLC‐QQQ‐MS) method was utilised to determine 44 major components. Cosine similarity was used to evaluate the similarities among 20 batches of LQL based on the quantitative results of 44 major components. The physicochemical properties, structure, composition, and contents of saccharide in LQL were detected by a combination of chemical and instrumental analysis.
Results
A total of 44 compounds, including flavonoids, iridoid glycosides, alkaloids, and nucleosides, were accurately determined. The 20 batches of LQL were remarkably similar (> 0.95). In addition, d ‐glucose, galactose, d ‐glucuronic acid, arabinose, and d ‐mannose were detected in saccharide of LQL. The contents of saccharide in LQL were 13.52–21.09 mg/ml.
Conclusions
The established methods can be applied for the comprehensive quality control of LQL, including characterisation of saccharide and quantification of representative components. Our study will provide a robust chemical foundation for disclosing the quality markers of its therapeutic effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
- Yangtze River Pharmaceutical Group Jiangsu Long Feng Tang Traditional Chinese Medicine Co., Ltd, Nanjing, China.
ORCID-Profile: Hua Yang
Förderung
- National Natural Science Foundation of China
- Key Research and Development project of Shandong Province
- State Key Laboratory of Natural Medicines, China Pharmaceutical University
Zitieren
APA
Zhao, H. L., Liu, R. Z., Ding, M., Fan, Y. L., Lin, B. B., Lu, H. W., Wen, X. D., Li, P., & Yang, H. (2023). Determination of 44 major components and chemical profiling of saccharide in Chinese medicinal formula Lanqin Oral Liquid. Phytochemical Analysis. https://doi.org/10.1002/pca.3236
Vancouver
Zhao HL, Liu RZ, Ding M, Fan YL, Lin BB, Lu HW, et al. Determination of 44 major components and chemical profiling of saccharide in Chinese medicinal formula Lanqin Oral Liquid. Phytochemical Analysis. 2023. doi:10.1002/pca.3236
BibTeX
@article{Zhao2023,
author = {Zhao, Heng-Li and Liu, Run-Zhou and Ding, Meng and Fan, Ya-Liu and Lin, Bin-Bin and Lu, Hong-Wei and Wen, Xiao-Dong and Li, Ping and Yang, Hua},
title = {Determination of 44 major components and chemical profiling of saccharide in Chinese medicinal formula Lanqin Oral Liquid},
journal = {Phytochemical Analysis},
year = {2023},
doi = {10.1002/pca.3236}
}
EUVIMED